RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,430.00
+50.00 (0.93%)
At close: Oct 23, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 47.06 billion as of October 23, 2026. It is the 32,618th most valuable company in the world and the 1,853rd biggest in South Korea. Its market cap has decreased by 27.70% in one year.
Market Cap
47.06B
Enterprise Value
46.54B
Revenue
141.42B
Global Rank
Country Rank
#1,853 South Korea
PE Ratio
6.99
ChartMarket Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 47.06B, a decrease of -67.13%. That is a compound annual growth rate of -23.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 47.06B | -26.62% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 63.08B |
| Sinsin Pharmaceutical | 61.90B |
| GL Pharm Tech | 55.76B |
| BL Pharmtech | 53.06B |
| Hwail Pharmaceutical | 49.81B |
| Jin Yang Pharmaceutical | 46.86B |
| GeneBioTech Co. ,Ltd | 44.52B |
| Organoidsciences | 40.17B |